Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | President and CMO | March 01, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,635 |
Ending reported balance
After 2025-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-01 · Exercise / conversion · Acquired 3,150 · Balance 58,150 F1: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). Row 2 · 2025-03-01 · Tax withholding · Disposed 10,515 · Balance 47,635 |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,850 |
Reported balance
After 2025-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-01 · Exercise / conversion · Disposed 3,150 · Balance 11,850 F1: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-01 · Disposition to issuer · Disposed 11,850 · Balance 0 F1: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2025-03-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 30,000 F2: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2025-03-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 30,000 F3: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2032-02-29 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2025-03-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 15,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.15 · Expires 2033-02-28 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2025-03-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 30,000 F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.87 · Expires 2034-02-28 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2025-03-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 30,000 F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850).
F2: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
F3: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 3, 2025 23:02 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Disposition to issuerPerformance Based Restricted · Derivative | 11,850 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031110 · ownership.xml · derivative · entry 4 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,850 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). F1 · derivative.expiration_date: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:02 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 3,150 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031110 · ownership.xml · derivative · entry 3 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,850 Underlying: Common Stock · 3,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). F1 · derivative.expiration_date: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:02 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 10,515 | $3.01 | $31,650.15 |
DisclosureSEC source: 0000950170-25-031110 · ownership.xml · nonDerivative · entry 2 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,635 Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:02 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031110 · ownership.xml · nonDerivative · entry 1 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these 15,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (3,150), and the remaining 79% of the target number has been forfeited (11,850). Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:16 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | SaleCommon Stock | 23,875 | $3.53 | $84,159.38 |
DisclosureSEC source: 0000950170-25-026691 · ownership.xml · nonDerivative · entry 1 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · price: These shares were sold in a series of transactions at a sales price of $3.525 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.